2012-16675. Meeting of the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM)
-
Start Preamble
AGENCY:
Division of the National Toxicology Program (DNTP), National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), HHS.
ACTION:
Meeting announcement and request for comments.
SUMMARY:
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of SACATM on September 5-6, 2012, at the Rodbell Auditorium, Rall Building at the NIEHS, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709. The meeting is open to the public with attendance limited only by the space available. The meeting will be webcast through a link at (http://www.niehs.nih.gov/news/video/live). SACATM advises the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), and the Director of the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and activities of NICEATM.
DATES:
The SACATM meeting will be held on September 5-6, 2012. The meeting is tentatively scheduled from 8:30 a.m. Eastern Daylight Time to 5:30 p.m. on September 5 and 8:30 a.m. until adjournment on September 6. All individuals who plan to attend are encouraged to register online at the NTP Web site (http://ntp.niehs.nih.gov/go/32822) by August 29, 2012. In order to facilitate planning, persons wishing to make an oral presentation are asked to notify Dr. Lori White, NTP Designated Federal Officer, via online registration, phone, or email by August 29, 2012 (see ADDRESSES below). Written comments should also be received by August 29, 2012, to enable review by SACATM and NIEHS/DNTP staff before the meeting. TTY users should contact the Federal TTY Relay Service at 800-877-8339. Requests should be made at least 5 business days in advance of the event.
ADDRESSES:
The SACATM meeting will be held at the Rodbell Auditorium, Rall Building at the NIEHS, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709. Public comments and other correspondence should be directed to Dr. Lori White (Office of Liaison, Policy and Review, DNTP, NIEHS, P.O. Box 12233, MD K2-03, Start Printed Page 40359Research Triangle Park, NC 27709; telephone: 919-541-9834 or email: whiteld@niehs.nih.gov). Courier address: NIEHS, 530 Davis Drive, Room 2136, Morrisville, NC 27560.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Preliminary Agenda and Other Meeting Information
A preliminary agenda, roster of SACATM members, background materials, public comments, and any additional information, when available, will be posted on the SACATM meeting Web site (http://ntp.niehs.nih.gov/go/32822) or available upon request (see ADDRESSES above). Following the meeting, summary minutes will be prepared and available on the SACATM Web site or upon request.
Request for Comments
Both written and oral public input on the agenda topics is invited. Written comments received in response to this notice will be posted on the NTP Web site. Persons submitting written comments should include their name, affiliation (if applicable), and sponsoring organization (if any) with the document. Time is allotted during the meeting for presentation of oral comments and each organization is allowed one time slot per public comment period. At least 7 minutes will be allotted for each speaker, and if time permits, may be extended up to 10 minutes at the discretion of the chair. Registration for oral comments will also be available on-site, although time allowed for presentation by on-site registrants may be less than for pre-registered speakers and will be determined by the number of persons who register at the meeting. In addition to in-person oral comments at the meeting, public comments can be presented by teleconference line. There will be 50 lines for this call; availability will be on a first-come, first-served basis. The available lines will be open from 8:00 a.m. until 5:30 p.m. on September 5 and 8:30 a.m. to adjournment on September 6, although public comments will be received only during the formal public comment periods, which will be indicated on the preliminary agenda. The access number for the teleconference line will be provided to registrants by email prior to the meeting.
Persons registering to make oral comments are asked to do so through the online registration form (http://ntp.niehs.nih.gov/go/32822) and to send a copy of their statement to Dr. White (see ADDRESSES above) by August 29, 2012, to enable review by SACATM, NICEATM-ICCVAM, and NIEHS/DNTP staff prior to the meeting. Written statements can supplement and may expand the oral presentation. If registering on-site and reading from written text, please bring 40 copies of the statement for distribution and to supplement the record.
Background Information on ICCVAM, NICEATM, and SACATM
ICCVAM is an interagency committee composed of representatives from 15 Federal regulatory and research agencies that require, use, generate, or disseminate toxicological and safety testing information. ICCVAM conducts technical evaluations of new, revised, and alternative safety testing methods with regulatory applicability and promotes the scientific validation and regulatory acceptance of toxicological and safety testing methods that more accurately assess the safety and hazards of chemicals and products and that reduce, refine (decrease or eliminate pain and distress), or replace animal use. The ICCVAM Authorization Act of 2000 (42 U.S.C. 285 l-3) established ICCVAM as a permanent interagency committee of the NIEHS under NICEATM. NICEATM administers ICCVAM, provides scientific and operational support for ICCVAM-related activities, and conducts independent validation studies to assess the usefulness and limitations of new, revised, and alternative test methods and strategies. NICEATM and ICCVAM work collaboratively to evaluate new and improved test methods and strategies applicable to the needs of U.S. Federal agencies. NICEATM and ICCVAM welcome the public nomination of new, revised, and alternative test methods and strategies for validation studies and technical evaluations. Additional information about ICCVAM and NICEATM can be found on the NICEATM-ICCVAM Web site (http://iccvam.niehs.nih.gov).
SACATM was established in response to the ICCVAM Authorization Act [Section 285 l-3(d)] and is composed of scientists from the public and private sectors. SACATM advises ICCVAM, NICEATM, and the Director of the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and activities of NICEATM. SACATM provides advice on priorities and activities related to the development, validation, scientific review, regulatory acceptance, implementation, and national and international harmonization of new, revised, and alternative toxicological test methods. Additional information about SACATM, including the charter, roster, and records of past meetings, can be found at http://ntp.niehs.nih.gov/go/167.
Start SignatureDated: June 27, 2012.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2012-16675 Filed 7-6-12; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Comments Received:
- 0 Comments
- Published:
- 07/09/2012
- Department:
- Health and Human Services Department
- Entry Type:
- Notice
- Action:
- Meeting announcement and request for comments.
- Document Number:
- 2012-16675
- Dates:
- The SACATM meeting will be held on September 5-6, 2012. The meeting is tentatively scheduled from 8:30 a.m. Eastern Daylight Time to 5:30 p.m. on September 5 and 8:30 a.m. until adjournment on September 6. All individuals who plan to attend are encouraged to register online at the NTP Web site (http://ntp.niehs.nih.gov/go/32822) by August 29, 2012. In order to facilitate planning, persons wishing to make an oral presentation are asked to notify Dr. Lori White, NTP Designated Federal Officer, ...
- Pages:
- 40358-40359 (2 pages)
- PDF File:
- 2012-16675.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute